MIR-30C mimic

Intervention

1 paper2 findings

  • 1 lab in 1 country
  • Funders: National Institute of Diabetes and Digestive and Kidney Diseases and 2 more
  • Animals1

Outcomes

2

FOXO3

downin mice1

1 study
  1. MIR-30C mimic inhibits FOXO3 in mice.

    “reduced fibrosis compared to EV-negative control by targeting Foxo3.”

    Animalsin liver, via EVs transfected with miR-30c mimicliver

    Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis

    Aging cell13 Sep 2024

More on FOXO3

Liver fibrosis

downin mice1

1 study
  1. MIR-30C mimic decreases liver fibrosis in mice.

    “Treatment of aged mice with EVs transfected with miR-30c mimic reduced stellate cell activation in the liver and reduced fibrosis”

    Animalsin aged miceliver

    Extracellular vesicle-encapsulated miR-30c-5p reduces aging-related liver fibrosis

    Aging cell13 Sep 2024

More on Liver fibrosis

Latest